tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sun Pharma’s New Study on Actinic Keratosis Treatment: What Investors Need to Know
PremiumCompany AnnouncementsSun Pharma’s New Study on Actinic Keratosis Treatment: What Investors Need to Know
3M ago
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
Premium
Company Announcements
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
3M ago
Sun Pharma’s Alopecia Areata Study: A Potential Game Changer?
Premium
Company Announcements
Sun Pharma’s Alopecia Areata Study: A Potential Game Changer?
3M ago
Sun Pharma’s New Study on Tildrakizumab: A Potential Game Changer for Genital Psoriasis
PremiumCompany AnnouncementsSun Pharma’s New Study on Tildrakizumab: A Potential Game Changer for Genital Psoriasis
6M ago
Sun Pharma’s Promising Phase 3 Study on Genital Psoriasis Treatment
Premium
Company Announcements
Sun Pharma’s Promising Phase 3 Study on Genital Psoriasis Treatment
6M ago
Sun Pharma’s Tildrakizumab Study: A Promising Step in Genital Psoriasis Treatment
Premium
Company Announcements
Sun Pharma’s Tildrakizumab Study: A Promising Step in Genital Psoriasis Treatment
7M ago
Philogen Withdraws Nidlegy™ Application, Plans Resubmission
PremiumCompany AnnouncementsPhilogen Withdraws Nidlegy™ Application, Plans Resubmission
7M ago
Sun Pharma Schedules Analyst and Investor Meeting
Premium
Company Announcements
Sun Pharma Schedules Analyst and Investor Meeting
7M ago
Sun Pharma’s Sonidegib Safety Study: Key Insights for Investors
Premium
Company Announcements
Sun Pharma’s Sonidegib Safety Study: Key Insights for Investors
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100